Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Maheswaran

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Tropical Doctor|June 26, 2013
Novel multidrug therapy for disseminated rhinosporidiosis, refractory to dapsone – case reportLeni George, Peter Dincy, Manu Chopra, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Physical and functional interaction between WT1 and p53 proteinsS Maheswaran, S Park, A Bernard, et al.
Nature Genetics|November 14, 1997
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumourS B Lee, K A Kolquist, K Nichols, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma modelV Gupta, J L Carey, H Kawakubo, et al.
Nature Genetics|August 1, 1993
The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesotheliomaS Park, M Schalling, A Bernard, et al.
The Journal of Biological Chemistry|May 18, 2001
Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivoD L Segev, Y Hoshiya, A E Stephen, et al.
Science (New York, N.Y.)|December 24, 1993
WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variantD A Haber, S Park, S Maheswaran, et al.
The EMBO Journal|October 2, 1995
WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosisC Englert, X Hou, S Maheswaran, et al.
Oncogene|February 23, 2011
Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinibF Takahashi, N Chiba, K Tajima, et al.
The Journal of Biological Chemistry|June 30, 2000
Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathwayD L Segev, T U Ha, T T Tran, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Tropical Doctor|June 26, 2013
Novel multidrug therapy for disseminated rhinosporidiosis, refractory to dapsone – case reportLeni George, Peter Dincy, Manu Chopra, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Physical and functional interaction between WT1 and p53 proteinsS Maheswaran, S Park, A Bernard, et al.
Nature Genetics|November 14, 1997
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumourS B Lee, K A Kolquist, K Nichols, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma modelV Gupta, J L Carey, H Kawakubo, et al.
Nature Genetics|August 1, 1993
The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesotheliomaS Park, M Schalling, A Bernard, et al.
The Journal of Biological Chemistry|May 18, 2001
Mullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivoD L Segev, Y Hoshiya, A E Stephen, et al.
Science (New York, N.Y.)|December 24, 1993
WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variantD A Haber, S Park, S Maheswaran, et al.
The EMBO Journal|October 2, 1995
WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosisC Englert, X Hou, S Maheswaran, et al.
Oncogene|February 23, 2011
Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinibF Takahashi, N Chiba, K Tajima, et al.
The Journal of Biological Chemistry|June 30, 2000
Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathwayD L Segev, T U Ha, T T Tran, et al.
Pageof 4